Medigen Biotechnology Corp. (TPEX: 3176)

Medigen Biotechnology Revenue

Medigen Biotechnology had revenue of 436.64M TWD in the quarter ending September 30, 2024, with 4.74% growth. This brings the company's revenue in the last twelve months to 1.41B, up 42.68% year-over-year. In the year 2023, Medigen Biotechnology had annual revenue of 1.16B with 9.64% growth.

• Revenue (ttm): 1.41B
• Revenue Growth: +42.68%
• P/S Ratio: 3.11
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 4.39B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.16B	101.77M	9.64%
Dec 31, 2022	1.06B	-2.87B	-73.08%
Dec 31, 2021	3.92B	3.31B	537.17%
Dec 31, 2020	615.54M	63.20M	11.44%
Dec 31, 2019	552.35M	145.04M	35.61%